PH-797804 is a potent and selectiove inhibitor of p38 mitogen-activated protein (MAP) kinase. PH-797804 reduces tumor growth of the three PDXs, which correlates with impaired colon tumor cell proliferation and survival. The inhibition of p38 MAPK in PDXs results in downregulation of the IL-6/STAT3 signaling pathway, which is a key regulator of colon tumorigenesis. PH-797804 may have therapeutic interest for colon cancer treatment.
p38 MAPK Inhibitors Related Products:
SB203580; Doramapimod; SB-202190; VX-702; Neflamapimod; TAK-715; R1487 HCl; SB239063; Losmapimod; Ralimetinib dimesylate